red wine

• Source: drugdu
• 177
• July 10, 2017

Drugdu.com(“Ddu”) attended Myanmar PHAR-MED EXPO 2017 receiving high praise

The 5th International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) was grandly held in Myanmar's capital, Yangon from July 5 - 7, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Drugdu.com (“Ddu”) participated in the exhibition and gaining an outstanding reputation from a number of exhibitors because of its business concept and service pattern.

• Source: Ddu
• 567
• July 8, 2017

Sanofi snaps up Protein Sciences for $650 million

Sanofi is to buy private US vaccines biotech Protein Sciences in a deal valued at up to $750 million, in a move to bolster its vaccines portfolio.

• Source: pharmatimes
• 449
• July 7, 2017

Tumor-targeting MRI contrast developed, based on human protein

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including early stage tumor detection because of the enhanced MRI contrast, according to Dr. Han, associate professor of biochemistry & molecular pharmacology at University of Massachusetts Medical School.

• Source: drugdu
• 421
• July 7, 2017

Trillion in search of new partners

Trillium Therapeutics is seeking new partners as it looks over its pipeline with an eye to the future.

• Source: fiercebiotech
• 747
• July 5, 2017

MPs keen for close collaboration with EMA post Brexit

British MPs say they are keen to secure a close working relationship with the European Union on drug regulation post Brexit to protect patient health and investment in the UK’s life sciences sector.

• Source: pharmatimes
• 836
• July 4, 2017

How to Develop The Indonesian Market?

It is a common problem that concerned us. As a global pharmaceuticals and medical devices B2B online platform, Ddu invited Sherlock Chen, a senior biotech practitioner, to talk about how to develop the Indonesian market.

• Source: Ddu
• 975
• July 2, 2017

Drugdu.com (“Ddu”) to attend the PHAR-MED EXPO 2017

The 5th Myanmar International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) will be held in Myanmar's capital, Yangon, during July 5 - 7, 2017. Drugdu.com(“Ddu”), the first global pharmaceuticals and medical devices B2B online platform, will be participating in the exhibition to showcase the new method of cross-border medical trade from China.

• Source: Ddu
• 399
• July 1, 2017

Novartis bags first-line approval for Zykadia

The European Commission has expanded the scope of Novartis’ Zykadia to include the first line treatment of patients with non-small cell lung cancer (NSCLC) whose tumours are anaplastic lymphoma kinase (ALK)-positive.

• Source: pharmatimes
• 491
• June 30, 2017

Beta blockers may protect against heart failure

In a study conducted at York University, scientists came to the astonishing conclusion that beta blockers could protect against heart failure. This was one of the latest discoveries in a field with endless treatments managing symptoms though previously damage sustained to the heart can’t be revered.

• Source:  Ddu
• 425
• June 30, 2017